Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
WEDNESDAY, April 22, 2020 (HealthDay News) — There is no proven drug treatment for COVID-19 patients, according to a panel of experts convened by the U.S. National Institute of Allergy and Infectious Diseases.
The panel’s guidelines, issued Tuesday, refute claims that the malaria drugs hydroxychloroquine and chloroquine can treat COVID-19, The New York Times reported.
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial to gather data on whether those treatments are effective, the panel recommended.
The panel’s guidelines confirm many doctors’ concerns that not enough is known about COVID-19 or how to fight it, The Times reported.
The New York Times Article
Copyright © 2020 HealthDay. All rights reserved.
